Tempus AI (TEM) EV/FCF: History & Chart

Tempus AI, Inc. (TEM)TEMTempus AI, Inc.

About Tempus AI, Inc.

Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests. The company also provides Lens, a software application for life sciences and advanced precision research; diagnostics services, such as NGS diagnostics, PCR profiling, and other anatomic and molecular pathology tests; and large-panel solid tumor and hematologic testing through multiple assays, with its core clinical assay (xT and xR) offering large panel DNA, RNA full transcriptome, and incidental germline findings through normal blood or saliva analyses. In addition, it provides genetic tests focused on inherited conditions; an nP assay for pharmacogenomic testing for patients with psychiatric conditions, including depression, general anxiety disorder, bipolar disorder, and other relevant diagnoses; Insights, which licenses libraries of linked, de-identified clinical, molecular, and imaging data; Organoids, a tumor derived biological modeling. Further, the company offers Trials for clinical trial matching services; Next, an AI platform; Algos, an algorithm-based diagnostics application. It has Strategic Collaborations with AstraZeneca AB, Pathos AI, Inc., GlaxoSmithKline, Merck, and Recursion Pharmaceuticals, Inc. Additionally, it also has a strategic collaboration with Blood Cancer United to develop registry for pediatric acute myeloid leukemia. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.

Chicago, IL

3,800 employees

www.tempus.com

Healthcare / Medical - Healthcare Information Services

Sector: Healthcare
Industry: Medical - Healthcare Information Services
CEO: Eric Lefkofsky

View full financials

NAME	MARKET CAP	EV/FCF RATIO	TTM	3Y	5Y
Tempus AI, Inc. (TEM)	$7.47B	N/A	N/A	N/A	N/A
Oscar Health, Inc. (OSCR)vs ›	$7.31B	1.76x	2.27x	4.04x	4.29x
Bio-Rad Laboratories, Inc. (BIO)vs ›	$8.50B	26.17x	25.28x	40.71x	50.84x
Hims & Hers Health, Inc. (HIMS)vs ›	$6.27B	96.58x	89.72x	73.07x	73.07x
Henry Schein, Inc. (HSIC)vs ›	$9.74B	31.39x	29.48x	26.73x	24.13x
Universal Health Services, Inc. (UHS)vs ›	$9.75B	16.35x	19.13x	24.82x	59.27x
Molina Healthcare, Inc. (MOH)vs ›	$10.31B	33.59x	27.97x	45.01x	29.55x
Walgreens Boots Alliance, Inc. (WBA)vs ›	$10.37B	66.60x	67.40x	78.57x	42.55x
Charles River Laboratories International, Inc. (CRL)vs ›	$10.91B	35.67x	23.06x	28.53x	35.00x
Bio-Techne Corporation (TECH)vs ›	$11.21B	41.98x	39.20x	45.50x	49.62x

NAME

MARKET CAP

EV/FCF RATIO

TTM

Tempus AI, Inc. (TEM)

$7.47B

N/A

Oscar Health, Inc. (OSCR)vs ›

$7.31B

1.76x

2.27x

4.04x

4.29x

Bio-Rad Laboratories, Inc. (BIO)vs ›

$8.50B

26.17x

25.28x

40.71x

50.84x

Hims & Hers Health, Inc. (HIMS)vs ›

$6.27B

96.58x

89.72x

73.07x

Henry Schein, Inc. (HSIC)vs ›

$9.74B

31.39x

29.48x

26.73x

24.13x

Universal Health Services, Inc. (UHS)vs ›

$9.75B

16.35x

19.13x

24.82x

59.27x

Molina Healthcare, Inc. (MOH)vs ›

$10.31B

33.59x

27.97x

45.01x

29.55x

Walgreens Boots Alliance, Inc. (WBA)vs ›

$10.37B

66.60x

67.40x

78.57x

42.55x

Charles River Laboratories International, Inc. (CRL)vs ›

$10.91B

35.67x

23.06x

28.53x

35.00x

Bio-Techne Corporation (TECH)vs ›

$11.21B

41.98x

39.20x

45.50x

49.62x

EV/FCF Ratio: N/A

TEM EV/FCF Ratio Metrics

TEM Competitors' EV/FCF Ratio

Cash Flow Valuation Comparison

EV/FCF Ratio Formula & Definition

Related Metrics